Market Overview:
The global ophthalmology amniotic membrane market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye disorders, rising awareness about ophthalmic treatments and procedures, and technological advancements in the field of ophthalmology. Based on type, the global ophthalmology amniotic membrane market is segmented into cryopreservation of amniotic membrane, lyophilized amniotic membrane, and others. Cryopreservation of amniotic membrane held a dominant share in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to its advantages such as easy storage and transportation, low cost compared with other types of membranes available in the market, no risk of contamination or cross-infection between patients due to sharing same donor material etc. Lyophilized membranes are also gaining traction due their benefits such as longer shelf life than fresh membranes and no risk for microbial contamination etc., which are likely to boost their demand over the forecast period. Based on application, adult held a dominant share in 2017 owingto high incidence rateof various eye disordersin adults across different regions worldwide .
Product Definition:
The ophthalmology amniotic membrane is a thin film that is derived from the amniotic sac. This membrane has been found to be effective in promoting healing and reducing inflammation following various eye surgeries.
Cryopreservation of Amniotic Membrane:
The amniotic membrane is a thin film that covers the inner surface of the fetus in its mother's uterus. The purpose of this membrane is to separate the fetal from the maternal blood and provide insulation for maintaining body temperature during pregnancy. It also acts as a shield against infection and other harmful factors present in pregnant women or their surroundings.
Lyophilized Amniotic Membrane:
Lyophilized amniotic membrane is a product that is used in ophthalmic surgeries. It’s an all-natural occurring protective coating around the innermost layer of the eye which is made up of water, protein, and cholesterol. The membrane acts as a shield to protect the sensitive tissue inside from foreign particles and helps in increasing life expectancy of aged people with dry eyes by providing them with necessary moisture.
Application Insights:
The application of the product includes adult and children. Among these, the use of amniotic membrane in treating ophthalmic diseases in children is expected to dominate the market throughout the forecast period owing to increasing number of approvals by regulatory authorities for this indication.
For instance, according to FDA approval issued on June 29, 2017, Hyosung Pharmaceutical Co., Ltd manufactured a device named ¢â‚¬Å“AMNIOFlux¢â‚¬ which was approved for treatment of amblyopia (lazy eye) in patients aged 6 years and above. This approval was based on data from clinical trials which showed that approximately 70% improvement rate can be expected with this procedure when compared with other treatments such as glasses or surgery. Such factors are anticipated to boost overall demand for amniotic membranes over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing R&D investments by major companies, rising incidences of retinal diseases, and growing awareness about ophthalmology disorders. In addition, presence of reimbursement facilities for amniotic membrane transplantation is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and rising disposable income especially in developing countries such as India and China.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the ophthalmology amniotic membrane market. According to a study by the World Health Organization (WHO), over 285 million people are affected by visual impairment, which is expected to increase to more than 380 million by 2020. This growing population base is likely to create demand for ophthalmic products and services, thereby driving the growth of the ophthalmology amniotic membrane market.
- Rising awareness about benefits of using amniotic membranes: There is a rising awareness among patients about the benefits of using amniotic membranes in ophthalmology procedures. This has led to an increase in demand for these products, thereby propelling the growth of this market.
- Technological advancements in surgical procedures: The technological advancements in surgical procedures have resulted in better outcomes for patients undergoing such surgeries. This has increased adoption rates of these technologies, consequently boosting demand for related products and services, including those used in ophthalmology surgeries such as amniotic membranes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ophthalmology Amniotic Membrane Market Research Report
By Type
Cryopreservation of Amniotic Membrane, Lyophilized Amniotic Membrane, Others
By Application
Adult, Children
By Companies
Derma Sciences, FzioMed, Alliqua BioMedical, Skye Biologics, IOP Ophthalmics, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Ophthalmology Amniotic Membrane Market Report Segments:
The global Ophthalmology Amniotic Membrane market is segmented on the basis of:
Types
Cryopreservation of Amniotic Membrane, Lyophilized Amniotic Membrane, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Derma Sciences
- FzioMed
- Alliqua BioMedical
- Skye Biologics
- IOP Ophthalmics
- ...
Highlights of The Ophthalmology Amniotic Membrane Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cryopreservation of Amniotic Membrane
- Lyophilized Amniotic Membrane
- Others
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ophthalmology Amniotic Membrane Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The amniotic membrane is a thin, transparent sheet of tissue that lines the inside of the uterus. It helps protect the developing baby during pregnancy and childbirth.
Some of the key players operating in the ophthalmology amniotic membrane market are Derma Sciences, FzioMed, Alliqua BioMedical, Skye Biologics, IOP Ophthalmics.
The ophthalmology amniotic membrane market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ophthalmology Amniotic Membrane Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ophthalmology Amniotic Membrane Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ophthalmology Amniotic Membrane Market - Supply Chain
4.5. Global Ophthalmology Amniotic Membrane Market Forecast
4.5.1. Ophthalmology Amniotic Membrane Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ophthalmology Amniotic Membrane Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ophthalmology Amniotic Membrane Market Absolute $ Opportunity
5. Global Ophthalmology Amniotic Membrane Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
5.3.1. Cryopreservation of Amniotic Membrane
5.3.2. Lyophilized Amniotic Membrane
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ophthalmology Amniotic Membrane Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Children
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ophthalmology Amniotic Membrane Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ophthalmology Amniotic Membrane Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ophthalmology Amniotic Membrane Demand Share Forecast, 2019-2029
9. North America Ophthalmology Amniotic Membrane Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
9.7.1. Cryopreservation of Amniotic Membrane
9.7.2. Lyophilized Amniotic Membrane
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ophthalmology Amniotic Membrane Demand Share Forecast, 2019-2029
10. Latin America Ophthalmology Amniotic Membrane Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
10.7.1. Cryopreservation of Amniotic Membrane
10.7.2. Lyophilized Amniotic Membrane
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ophthalmology Amniotic Membrane Demand Share Forecast, 2019-2029
11. Europe Ophthalmology Amniotic Membrane Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
11.7.1. Cryopreservation of Amniotic Membrane
11.7.2. Lyophilized Amniotic Membrane
1.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ophthalmology Amniotic Membrane Demand Share, 2019-2029
12. Asia Pacific Ophthalmology Amniotic Membrane Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Children
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
12.7.1. Cryopreservation of Amniotic Membrane
12.7.2. Lyophilized Amniotic Membrane
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ophthalmology Amniotic Membrane Demand Share, 2019-2029
13. Middle East & Africa Ophthalmology Amniotic Membrane Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Children
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ophthalmology Amniotic Membrane Market Size and Volume Forecast by Type
13.7.1. Cryopreservation of Amniotic Membrane
13.7.2. Lyophilized Amniotic Membrane
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ophthalmology Amniotic Membrane Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Ophthalmology Amniotic Membrane Market: Market Share Analysis
14.2. Ophthalmology Amniotic Membrane Distributors and Customers
14.3. Ophthalmology Amniotic Membrane Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Derma Sciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. FzioMed
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Alliqua BioMedical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Skye Biologics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. IOP Ophthalmics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ...
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
